Registro:

Referencias:

• Nordestgaard, B.G., Chapman, M.J., Humphries, S.E., Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease (2013) Eur Heart J, 34 (45), pp. 3478-3490
• Ademi, Z., Watts, G.F., Pang, J., Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia (2014) J Clin Lipidol, 8 (4), pp. 390-400
• Watts, G.F., Gidding, S., Wierzbicki, A.S., Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation (2014) J Clin Lipidol, 8 (2), pp. 148-172
• Pang, J., Lansberg, P.J., Watts, G.F., International developments in the care of familial hypercholesterolemia: where now and where to next? (2016) J Atheroscler Thromb, 23 (5), pp. 505-519
• Hobbs, H.H., Brown, M.S., Goldstein, J.L., Molecular genetics of the LDL receptor gene in familial hypercholesterolemia (1992) Hum Mutat, 1 (6), pp. 445-466
• Alberto, F.L., Figueiredo, M.S., Zago, M.A., Araújo, A.G., Dos-Santos, J.E., The Lebanese mutation as an important cause of familial hypercholesterolemia in Brazil (1999) Braz J Med Biol Res, 32 (6), pp. 739-745
• Krisko, A., Etchebest, C., Theoretical model of human apolipoprotein B100 tertiary structure (2007) Proteins, 66 (2), pp. 342-358
• Abifadel, M., Guerin, M., Benjannet, S., Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia (2012) Atherosclerosis, 223 (2), pp. 394-400
• Caputo, M., Corach, D., Analysis of locus D9S1120 and its genetic admixture correlation in seven Argentina native American ethnic groups (2016) Am J Hum Biol, 28 (1), pp. 57-66
• Vaca, G., Vàzquez, A., Magaña, M.T., Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia (2011) Atherosclerosis, 218 (2), pp. 391-396
• Jannes, C.E., Santos, R.D., de Souza Silva, P.R., Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects (2015) Atherosclerosis, 238 (1), pp. 101-107
• Miller, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells (1988) Nucleic Acids Res, 16 (3), p. 1215
• Medeiros, A.M., Alves, A.C., Francisco, V., Bourbon, M., Update of the Portuguese familial hypercholesterolaemia study (2010) Atherosclerosis, 212 (2), pp. 553-558
• Richards, S., Aziz, N., Bale, S., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (2015) Genet Med, 17 (5), pp. 405-423
• Omasits, U., Ahrens, C.H., Müller, S., Wollscheid, B., Protter: interactive protein feature visualization and integration with experimental proteomic data (2014) Bioinformatics, 30 (6), pp. 884-886
• Mata, N., Alonso, R., Badimón, L., Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) (2011) Lipids Health Dis, 10, p. 94
• Santos, R.D., Gidding, S.S., Hegele, R.A., Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel (2016) Lancet Diabetes Endocrinol, 4, pp. 850-861
• Devoto, F.J., Argentine migration policy and movements of the European population (1876-1925) (1989) Estud Migr Latinoam, 4 (11), pp. 135-158
• Dedoussis, G.V.Z., Pitsavos, C., Kelberman, D., FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia (2003) Clin Genet, 64 (5), pp. 414-419
• Li, H., Liu, J., Identification of heterogeneous nuclear ribonucleoprotein K as a transactivator for human low density lipoprotein receptor gene transcription (2010) J Biol Chem, 285 (23), pp. 17789-17797
• De Castro-Orós, I., Pampín, S., Bolado-Carrancio, A., Functional analysis of LDLR promoter and 5′ UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia (2011) Hum Mutat, 32 (8), pp. 868-872
• Chmara, M., Wasag, B., Zuk, M., Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations (2010) J Appl Genet, 51 (1), pp. 95-106
• Leitersdorf, E., Tobin, E.J., Davignon, J., Hobbs, H.H., Common low-density lipoprotein receptor mutations in the French Canadian population (1990) J Clin Invest, 85 (4), pp. 1014-1023
• Mozas, P., Castillo, S., Tejedor, D., Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR (2004) Hum Mutat, 24 (2), p. 187
• Fouchier, S.W., Defesche, J.C., Umans-Eckenhausen, M.A., Kastelein, J.J., The molecular basis of familial hypercholesterolemia in the Netherlands (2001) Hum Genet, 109 (6), pp. 602-615
• Damgaard, D., Jensen, H.K., Jensen, J.M., The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population (2005) Atherosclerosis, 180 (1), pp. 155-160
• Cefalù, A.B., Barraco, G., Noto, D., Six novel mutations of the LDL receptor gene in FH kindred of Sicilian and Paraguayan descent (2006) Int J Mol Med, 17 (3), pp. 539-546
• Talmud, P.J., Shah, S., Whittall, R., Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study (2013) Lancet, 381 (9874), pp. 1293-1301
• Alves, A.C., Benito-Vicente, A., Etxebarria, A., Medeiros, A.M., Martin, C., Genetic diagnosis of familial hypercholesterolaemia: the importance of an integrated analysis of clinical, molecular and functional data (2015) Atherosclerosis, 241 (1), pp. e111-e112. , http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71970391, Available at:
• Santos, P.C.J.L., Morgan, A.C., Jannes, C.E., Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia (2014) Atherosclerosis, 233 (1), pp. 206-210
• Palacios, L., Grandoso, L., Cuevas, N., Molecular characterization of familial hypercholesterolemia in Spain (2012) Atherosclerosis, 221 (1), pp. 137-142

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------